Mylan launches Trilipix generic
Mylan Inc. has released fenofibric acid delayed-release capsules, a medication for treating high levels of cholesterol and triglycerides. The company said Monday that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched the product in dosages of 45 mg and 135 mg.